Substance Misuse Services
- Care Setting Overview
- Commissioning and Procurement Structure
- Regulatory and Statutory Requirements
- Service User Profile and Eligibility
- Service Specification Expectations
- Our Approach to Tender Writing for This Setting
- Core Method Statements for This Setting
- Workforce Model and Capacity
- Quality Assurance and Governance
- Mobilisation and Implementation
- Outcomes and Performance Framework
- Technology and Systems
- Partnership and System Integration
- Commercial and Pricing Considerations
- Common Bid Risks and Failure Points
- Evidence and Case Studies
- FAQs for This Care Setting
Live Tenders
Care Setting Overview
Substance misuse services provide support for individuals affected by drug and alcohol dependency, including residential rehabilitation, community-based recovery support, harm reduction services, and supported accommodation for people in recovery. The service model operates across a treatment spectrum from harm reduction through to abstinence-based recovery, depending on commissioner priorities and individual circumstances.
Commissioning and Procurement Structure
Substance misuse services are commissioned by local authority public health departments, NHS Integrated Care Boards, and the Office for Health Improvement and Disparities. Procurement includes competitive tender for community drug and alcohol services, framework agreements for residential rehabilitation, and grant funding for peer support and recovery services. The Government's 10-year drug strategy (From Harm to Hope) is driving increased investment and procurement activity.
Regulatory and Statutory Requirements
CQC registration is required for services providing personal care or accommodation with care. Services must comply with NICE guidelines for drug and alcohol treatment, Public Health England clinical guidance, and safeguarding duties. Prescribing services operate under additional pharmaceutical governance requirements.
Service User Profile and Eligibility
Adults and young people with drug and alcohol dependency, including those with co-occurring mental health conditions (dual diagnosis), people involved in the criminal justice system, people experiencing homelessness, and family members affected by someone else's substance misuse.
Service Specification Expectations
Specifications require evidence of clinical competence in substance misuse, harm reduction approaches, structured treatment programmes, recovery planning, aftercare and relapse prevention, family and carer support, criminal justice partnership, and outcome measurement against Public Health Outcomes Framework indicators.
Our Approach to Tender Writing for This Setting
We write substance misuse responses demonstrating clinical competence, recovery orientation, and partnership capability. Responses embed named treatment modalities, evidence-based interventions, and outcome data that aligns with national reporting requirements.
Core Method Statements for This Setting
Structured Treatment Programmes
Covers how the service delivers structured treatment including psychosocial interventions, group work, 1:1 recovery planning, and medical interventions where applicable.
Harm Reduction
Addresses naloxone distribution, needle exchange, safer injecting advice, and blood-borne virus testing and vaccination.
Recovery Planning and Aftercare
Details how recovery plans are developed with individuals, how aftercare is sustained, and how relapse prevention is embedded in the support model.
Criminal Justice Partnership
Covers how the service works with probation, courts, and prison services to support individuals with substance misuse within the criminal justice system.
Workforce Model and Capacity
Staffing includes recovery workers, clinical staff, prescribers, psychologists, peer support workers, and management. Training requirements include substance misuse-specific competencies, safeguarding, blood-borne virus awareness, overdose prevention, and motivational interviewing.
Quality Assurance and Governance
Quality is measured through treatment outcomes (NDTMS data), successful completions, representations, waiting times, safeguarding incident rates, and service user feedback.
Mobilisation and Implementation
Mobilisation involves clinical staff recruitment, prescribing governance setup, partnership establishment with criminal justice and health services, and NDTMS reporting configuration.
Outcomes and Performance Framework
KPIs include successful treatment completions, numbers in treatment, waiting times, drug and alcohol-related deaths, housing outcomes, employment outcomes, and criminal justice outcomes.
Technology and Systems
Systems include NDTMS-compatible case management platforms, prescribing systems, outcome recording, and data reporting tools.
Partnership and System Integration
Partners include GPs, pharmacies, mental health services, probation, police, housing providers, employment services, and peer support networks.
Commercial and Pricing Considerations
Pricing models include block contract values for community services and per-placement fees for residential rehabilitation. Commissioners assess cost against treatment outcomes and public health impact. Payment by results models are used in some areas.
Common Bid Risks and Failure Points
Providers fail when responses lack clinical competence evidence, omit harm reduction approaches, demonstrate weak criminal justice partnership, or fail to align outcomes with NDTMS reporting requirements.
Evidence and Case Studies
Evidence should include NDTMS outcome data, successful completion rates, case studies showing recovery journeys, and examples of partnership with criminal justice and health services.
FAQs for This Care Setting
What outcome data do substance misuse commissioners expect?
NDTMS data is the primary reporting framework. Commissioners score providers on successful completions, reduced representations, and contributions to public health outcomes.